| 0 |
CUTANEOUS T-CELL LYMPHOMA REFRACTORY |
7 |
0.3333 |
| 1 |
CUTANEOUS T-CELL LYMPHOMA STAGE I |
9 |
0.2500 |
| 2 |
SEZARY CELLS INCREASED |
2 |
0.2500 |
| 3 |
THYROID STIMULATING HORMONE DEFICIENCY |
8 |
0.2424 |
| 4 |
REGIONAL CHEMOTHERAPY |
1 |
0.1667 |
| 5 |
MYCOSIS FUNGOIDES REFRACTORY |
1 |
0.1667 |
| 6 |
CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS |
1 |
0.1250 |
| 7 |
CUTANEOUS T-CELL LYMPHOMA RECURRENT |
7 |
0.1111 |
| 8 |
CUTANEOUS T-CELL LYMPHOMA STAGE II |
2 |
0.0909 |
| 9 |
CUTANEOUS T-CELL LYMPHOMA STAGE IV |
3 |
0.0833 |
| 10 |
HYPO HDL CHOLESTEROLAEMIA |
1 |
0.0769 |
| 11 |
MYCOSIS FUNGOIDES RECURRENT |
2 |
0.0690 |
| 12 |
PSEUDO LYMPHOMA |
2 |
0.0571 |
| 13 |
MYCOSIS FUNGOIDES STAGE II |
1 |
0.0435 |
| 14 |
DIPHTHERIA |
2 |
0.0426 |
| 15 |
PYELECTASIA |
1 |
0.0370 |
| 16 |
MYCOSIS FUNGOIDES |
30 |
0.0365 |
| 17 |
SUPERINFECTION FUNGAL |
3 |
0.0353 |
| 18 |
SECONDARY HYPOTHYROIDISM |
5 |
0.0327 |
| 19 |
GOODPASTURE'S SYNDROME |
1 |
0.0294 |
| 20 |
GALLBLADDER FISTULA |
1 |
0.0294 |
| 21 |
APPLICATION SITE FISSURE |
2 |
0.0222 |
| 22 |
CUTANEOUS T-CELL LYMPHOMA |
27 |
0.0214 |
| 23 |
BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL |
1 |
0.0185 |
| 24 |
STAPHYLOCOCCAL IMPETIGO |
1 |
0.0175 |
| 25 |
LICHEN MYXOEDEMATOSUS |
1 |
0.0169 |
| 26 |
APPLICATION SITE CELLULITIS |
1 |
0.0149 |
| 27 |
HYPERVITAMINOSIS |
2 |
0.0145 |
| 28 |
PARESIS CRANIAL NERVE |
1 |
0.0143 |
| 29 |
SCLEREMA |
1 |
0.0123 |
| 30 |
CENTRAL HYPOTHYROIDISM |
4 |
0.0121 |
| 31 |
RETINOIC ACID SYNDROME |
2 |
0.0116 |
| 32 |
ELDERLY |
1 |
0.0112 |
| 33 |
HYPERTRIGLYCERIDAEMIA |
59 |
0.0101 |
| 34 |
POST INFLAMMATORY PIGMENTATION CHANGE |
4 |
0.0088 |
| 35 |
CHOLURIA |
3 |
0.0088 |
| 36 |
ANEURYSM REPAIR |
1 |
0.0088 |
| 37 |
LICHEN PLANOPILARIS |
1 |
0.0085 |
| 38 |
DACRYOCANALICULITIS |
1 |
0.0085 |
| 39 |
ACHROMOBACTER INFECTION |
1 |
0.0083 |
| 40 |
PALMOPLANTAR KERATODERMA |
6 |
0.0083 |
| 41 |
BRACHIOCEPHALIC VEIN THROMBOSIS |
1 |
0.0081 |
| 42 |
T-CELL LYMPHOMA |
9 |
0.0079 |
| 43 |
MEDICAL DEVICE SITE ERYTHEMA |
1 |
0.0078 |
| 44 |
LIPIDS ABNORMAL |
5 |
0.0069 |
| 45 |
SYMPTOM MASKED |
5 |
0.0069 |
| 46 |
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES |
2 |
0.0068 |
| 47 |
IMMUNOLOGY TEST ABNORMAL |
1 |
0.0064 |
| 48 |
MONONEURITIS |
1 |
0.0064 |
| 49 |
INTERNATIONAL NORMALISED RATIO |
1 |
0.0062 |
| 50 |
HYPOHIDROSIS |
3 |
0.0060 |
| 51 |
HAEMOCONCENTRATION |
1 |
0.0058 |
| 52 |
ALOPECIA SCARRING |
1 |
0.0055 |
| 53 |
ACANTHOSIS NIGRICANS |
1 |
0.0054 |
| 54 |
NEUTROPHILIC DERMATOSIS |
2 |
0.0051 |
| 55 |
CUTANEOUS LYMPHOMA |
1 |
0.0049 |
| 56 |
GLOMERULONEPHRITIS ACUTE |
1 |
0.0049 |
| 57 |
PRODUCT INTOLERANCE |
1 |
0.0045 |
| 58 |
EPIDERMOLYSIS |
2 |
0.0043 |
| 59 |
DYSLIPIDAEMIA |
22 |
0.0043 |
| 60 |
CANCER FATIGUE |
1 |
0.0042 |
| 61 |
BIOPSY SKIN ABNORMAL |
1 |
0.0042 |
| 62 |
TELANGIECTASIA |
4 |
0.0041 |
| 63 |
HODGKIN'S DISEASE |
3 |
0.0041 |
| 64 |
DRUG-DISEASE INTERACTION |
3 |
0.0041 |
| 65 |
LATEX ALLERGY |
1 |
0.0041 |
| 66 |
APPLICATION SITE INFECTION |
2 |
0.0039 |
| 67 |
CONJUNCTIVITIS VIRAL |
1 |
0.0038 |
| 68 |
THYROID HORMONES DECREASED |
3 |
0.0037 |
| 69 |
HYPEREOSINOPHILIC SYNDROME |
2 |
0.0037 |
| 70 |
PSEUDOLYMPHOMA |
2 |
0.0036 |
| 71 |
CELLULITIS ORBITAL |
2 |
0.0034 |
| 72 |
BACTERIAL TEST |
1 |
0.0034 |
| 73 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
2 |
0.0033 |
| 74 |
THYROXINE DECREASED |
2 |
0.0032 |
| 75 |
STAPHYLOCOCCAL BACTERAEMIA |
14 |
0.0032 |
| 76 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
1 |
0.0031 |
| 77 |
BLOOD TRIGLYCERIDES DECREASED |
1 |
0.0030 |
| 78 |
BRAIN MASS |
1 |
0.0030 |
| 79 |
PNEUMONIA ESCHERICHIA |
1 |
0.0029 |
| 80 |
DERMATITIS PSORIASIFORM |
6 |
0.0029 |
| 81 |
PNEUMONITIS CHEMICAL |
1 |
0.0029 |
| 82 |
LYMPHOMA TRANSFORMATION |
1 |
0.0028 |
| 83 |
VISCERAL LEISHMANIASIS |
2 |
0.0028 |
| 84 |
MILIA |
1 |
0.0028 |
| 85 |
CHOROIDITIS |
1 |
0.0027 |
| 86 |
SKIN DISCHARGE |
1 |
0.0026 |
| 87 |
GENITAL ULCERATION |
2 |
0.0026 |
| 88 |
COAGULATION TEST ABNORMAL |
2 |
0.0026 |
| 89 |
GALLBLADDER PERFORATION |
1 |
0.0026 |
| 90 |
CEREBELLAR STROKE |
1 |
0.0026 |
| 91 |
ASEPTIC NECROSIS BONE |
2 |
0.0026 |
| 92 |
SUPERINFECTION BACTERIAL |
2 |
0.0025 |
| 93 |
STICKY SKIN |
1 |
0.0025 |
| 94 |
DELIRIUM TREMENS |
1 |
0.0025 |
| 95 |
LIPIDS INCREASED |
5 |
0.0025 |
| 96 |
ARTERIAL THROMBOSIS LIMB |
1 |
0.0024 |
| 97 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 98 |
HYPOTHYROIDISM |
75 |
0.0023 |
| 99 |
RETICULOCYTE COUNT DECREASED |
1 |
0.0023 |
| 100 |
VENOUS THROMBOSIS |
9 |
0.0023 |
| 101 |
BLOOD TRIGLYCERIDES ABNORMAL |
2 |
0.0023 |
| 102 |
VITILIGO |
5 |
0.0021 |
| 103 |
DIFFUSE LARGE B-CELL LYMPHOMA |
16 |
0.0021 |
| 104 |
EXERCISE LACK OF |
1 |
0.0021 |
| 105 |
EPIDERMAL NECROSIS |
2 |
0.0021 |
| 106 |
CONTINUOUS HAEMODIAFILTRATION |
2 |
0.0020 |
| 107 |
ENDOCARDITIS STAPHYLOCOCCAL |
1 |
0.0020 |
| 108 |
DERMATITIS EXFOLIATIVE GENERALISED |
7 |
0.0020 |
| 109 |
METASTASES TO BONE MARROW |
1 |
0.0020 |
| 110 |
EXPOSURE VIA PARTNER |
1 |
0.0020 |
| 111 |
LYMPHOCYTIC INFILTRATION |
2 |
0.0020 |
| 112 |
PYODERMA |
1 |
0.0020 |
| 113 |
CAPILLARY LEAK SYNDROME |
4 |
0.0019 |
| 114 |
HYPERLIPASAEMIA |
1 |
0.0019 |
| 115 |
NAIL RIDGING |
1 |
0.0019 |
| 116 |
TUMOUR NECROSIS |
2 |
0.0019 |
| 117 |
HYPERMETABOLISM |
1 |
0.0019 |
| 118 |
INTERTRIGO |
1 |
0.0018 |
| 119 |
INTERLEUKIN LEVEL INCREASED |
1 |
0.0018 |
| 120 |
RENAL STONE REMOVAL |
1 |
0.0018 |
| 121 |
CATHETER SITE INFLAMMATION |
1 |
0.0018 |
| 122 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 123 |
OPHTHALMIC HERPES SIMPLEX |
1 |
0.0017 |
| 124 |
APPLICATION SITE DISCHARGE |
2 |
0.0017 |
| 125 |
PROCALCITONIN INCREASED |
2 |
0.0017 |
| 126 |
FACIAL PARESIS |
6 |
0.0017 |
| 127 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
1 |
0.0017 |
| 128 |
PITTING OEDEMA |
1 |
0.0016 |
| 129 |
PARACENTESIS |
1 |
0.0016 |
| 130 |
XEROSIS |
2 |
0.0016 |
| 131 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
2 |
0.0016 |
| 132 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
1 |
0.0016 |
| 133 |
APPLICATION SITE WARMTH |
2 |
0.0016 |
| 134 |
PAROTID GLAND ENLARGEMENT |
1 |
0.0015 |
| 135 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0015 |
| 136 |
HIGH DENSITY LIPOPROTEIN DECREASED |
5 |
0.0015 |
| 137 |
CHOREOATHETOSIS |
1 |
0.0015 |
| 138 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
1 |
0.0015 |
| 139 |
LEG AMPUTATION |
6 |
0.0015 |
| 140 |
CEREBRAL CYST |
1 |
0.0015 |
| 141 |
APPLICATION SITE INFLAMMATION |
2 |
0.0014 |
| 142 |
LEIOMYOMA |
1 |
0.0014 |
| 143 |
NUTRITIONAL CONDITION ABNORMAL |
1 |
0.0014 |
| 144 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 145 |
BLOOD TRIGLYCERIDES INCREASED |
25 |
0.0014 |
| 146 |
APPLICATION SITE ULCER |
1 |
0.0014 |
| 147 |
GRAFT VERSUS HOST DISEASE IN SKIN |
3 |
0.0014 |
| 148 |
LYMPHOPROLIFERATIVE DISORDER |
4 |
0.0014 |
| 149 |
SMALL FIBRE NEUROPATHY |
1 |
0.0014 |
| 150 |
MYOGLOBIN BLOOD INCREASED |
2 |
0.0013 |
| 151 |
PULMONARY ARTERY THROMBOSIS |
1 |
0.0013 |
| 152 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
3 |
0.0013 |
| 153 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 154 |
URINARY HESITATION |
3 |
0.0013 |
| 155 |
EROSIVE DUODENITIS |
1 |
0.0013 |
| 156 |
SINUSITIS FUNGAL |
1 |
0.0012 |
| 157 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 158 |
SKIN BACTERIAL INFECTION |
1 |
0.0012 |
| 159 |
SKIN EROSION |
4 |
0.0012 |
| 160 |
APPLICATION SITE DISCOLOURATION |
5 |
0.0012 |
| 161 |
RECALL PHENOMENON |
1 |
0.0012 |
| 162 |
GRANULOMA |
4 |
0.0012 |
| 163 |
AXONAL NEUROPATHY |
1 |
0.0011 |
| 164 |
ALOPECIA AREATA |
2 |
0.0011 |
| 165 |
HYPERCHOLESTEROLAEMIA |
11 |
0.0011 |
| 166 |
SKIN HYPOPIGMENTATION |
2 |
0.0011 |
| 167 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 168 |
ANOGENITAL WARTS |
1 |
0.0011 |
| 169 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 170 |
MUSCLE SWELLING |
1 |
0.0011 |
| 171 |
SKIN GRAFT |
1 |
0.0011 |
| 172 |
APPLICATION SITE DERMATITIS |
1 |
0.0011 |
| 173 |
PNEUMONIA CRYPTOCOCCAL |
1 |
0.0011 |
| 174 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 175 |
CEREBRAL PALSY |
1 |
0.0011 |
| 176 |
CEREBELLAR ATAXIA |
1 |
0.0010 |
| 177 |
CANCER SURGERY |
1 |
0.0010 |
| 178 |
HEPATIC CYTOLYSIS |
13 |
0.0010 |
| 179 |
OCCULT BLOOD POSITIVE |
2 |
0.0010 |
| 180 |
PRINZMETAL ANGINA |
1 |
0.0010 |
| 181 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 182 |
DERMATITIS EXFOLIATIVE |
5 |
0.0010 |
| 183 |
DEVICE RELATED SEPSIS |
2 |
0.0010 |
| 184 |
HYPOGONADISM |
1 |
0.0010 |
| 185 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
| 186 |
SKIN NECROSIS |
5 |
0.0010 |
| 187 |
SKIN PLAQUE |
8 |
0.0009 |
| 188 |
CD4 LYMPHOCYTES DECREASED |
2 |
0.0009 |
| 189 |
AORTIC DILATATION |
1 |
0.0009 |
| 190 |
APPLICATION SITE DRYNESS |
3 |
0.0009 |
| 191 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 192 |
GLOMERULONEPHRITIS MEMBRANOUS |
1 |
0.0009 |
| 193 |
HYPERLIPIDAEMIA |
10 |
0.0008 |
| 194 |
PYODERMA GANGRENOSUM |
3 |
0.0008 |
| 195 |
HEPATITIS CHOLESTATIC |
5 |
0.0008 |
| 196 |
DYSFUNCTIONAL UTERINE BLEEDING |
1 |
0.0008 |
| 197 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 198 |
ORAL MUCOSA EROSION |
1 |
0.0008 |
| 199 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
1 |
0.0008 |
| 200 |
HYPERNATRAEMIA |
4 |
0.0008 |
| 201 |
INTRADUCTAL PROLIFERATIVE BREAST LESION |
1 |
0.0008 |
| 202 |
ABORTION MISSED |
1 |
0.0008 |
| 203 |
NOCTURNAL DYSPNOEA |
1 |
0.0008 |
| 204 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 205 |
POLYARTHRITIS |
4 |
0.0008 |
| 206 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 207 |
ADRENAL INSUFFICIENCY |
9 |
0.0007 |
| 208 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 209 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 210 |
H1N1 INFLUENZA |
1 |
0.0007 |
| 211 |
INTESTINAL FISTULA |
1 |
0.0007 |
| 212 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 213 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 214 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 215 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 216 |
STEROID DIABETES |
1 |
0.0007 |
| 217 |
GENITAL HERPES |
1 |
0.0007 |
| 218 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
2 |
0.0006 |
| 219 |
NEOPLASM SKIN |
1 |
0.0006 |
| 220 |
SKIN INFECTION |
7 |
0.0006 |
| 221 |
ANGINA UNSTABLE |
4 |
0.0006 |
| 222 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 223 |
THERAPY CHANGE |
6 |
0.0006 |
| 224 |
METABOLIC SYNDROME |
1 |
0.0006 |
| 225 |
PAPILLOMA VIRAL INFECTION |
1 |
0.0006 |
| 226 |
COLONIC POLYP |
1 |
0.0006 |
| 227 |
SKIN MASS |
4 |
0.0006 |
| 228 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 229 |
SKIN LESION |
16 |
0.0006 |
| 230 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 231 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 232 |
HYPOPITUITARISM |
1 |
0.0006 |
| 233 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0006 |
| 234 |
LYMPHOPENIA |
8 |
0.0006 |
| 235 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 236 |
SKIN WEEPING |
2 |
0.0006 |
| 237 |
BLOOD CHOLESTEROL INCREASED |
26 |
0.0006 |
| 238 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 239 |
BLOOD THYROID STIMULATING HORMONE ABNORMAL |
1 |
0.0005 |
| 240 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 241 |
SMALL INTESTINAL PERFORATION |
1 |
0.0005 |
| 242 |
NARCOLEPSY |
1 |
0.0005 |
| 243 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
15 |
0.0005 |
| 244 |
INFECTED SKIN ULCER |
1 |
0.0005 |
| 245 |
SEPTIC SHOCK |
23 |
0.0005 |
| 246 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 247 |
BILE DUCT OBSTRUCTION |
1 |
0.0005 |
| 248 |
PARANASAL SINUS HYPERSECRETION |
2 |
0.0005 |
| 249 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 250 |
ATROPHY |
1 |
0.0005 |
| 251 |
PURULENCE |
1 |
0.0005 |
| 252 |
BICYTOPENIA |
1 |
0.0005 |
| 253 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 254 |
DRUG ERUPTION |
9 |
0.0005 |
| 255 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 256 |
APPLICATION SITE PAIN |
11 |
0.0005 |
| 257 |
SUDDEN HEARING LOSS |
1 |
0.0005 |
| 258 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 259 |
DISEASE PROGRESSION |
58 |
0.0005 |
| 260 |
APPLICATION SITE IRRITATION |
6 |
0.0005 |
| 261 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 262 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 263 |
ANAEMIA MACROCYTIC |
1 |
0.0005 |
| 264 |
RADIATION PNEUMONITIS |
1 |
0.0005 |
| 265 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 266 |
FACIAL PALSY |
1 |
0.0005 |
| 267 |
TUMOUR LYSIS SYNDROME |
4 |
0.0005 |
| 268 |
THYROID DISORDER |
7 |
0.0005 |
| 269 |
LYMPHOMA |
7 |
0.0005 |
| 270 |
FAECES PALE |
1 |
0.0004 |
| 271 |
RHINITIS ALLERGIC |
2 |
0.0004 |
| 272 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
1 |
0.0004 |
| 273 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 274 |
ADENOCARCINOMA |
1 |
0.0004 |
| 275 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 276 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 277 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
2 |
0.0004 |
| 278 |
METASTASES TO MENINGES |
1 |
0.0004 |
| 279 |
LICHENOID KERATOSIS |
1 |
0.0004 |
| 280 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 281 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
| 282 |
BLOOD CHOLESTEROL ABNORMAL |
2 |
0.0004 |
| 283 |
PAPULE |
3 |
0.0004 |
| 284 |
PUSTULE |
1 |
0.0004 |
| 285 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 286 |
MALIGNANT NEOPLASM PROGRESSION |
43 |
0.0004 |
| 287 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 288 |
SINUS OPERATION |
1 |
0.0004 |
| 289 |
APPLICATION SITE ERYTHEMA |
11 |
0.0004 |
| 290 |
GRAFT VERSUS HOST DISEASE |
3 |
0.0004 |
| 291 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 292 |
RASH PUSTULAR |
3 |
0.0004 |
| 293 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 294 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 295 |
APPLICATION SITE BURN |
2 |
0.0004 |
| 296 |
STAPHYLOCOCCAL SEPSIS |
2 |
0.0004 |
| 297 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 298 |
APPLICATION SITE SWELLING |
2 |
0.0004 |
| 299 |
ERYSIPELAS |
2 |
0.0004 |
| 300 |
TOXIC SKIN ERUPTION |
4 |
0.0004 |
| 301 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 302 |
DERMATOMYOSITIS |
1 |
0.0004 |
| 303 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 304 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 305 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 306 |
LOW DENSITY LIPOPROTEIN INCREASED |
3 |
0.0004 |
| 307 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 308 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 309 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 310 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
11 |
0.0004 |
| 311 |
FOLLICULITIS |
4 |
0.0004 |
| 312 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 313 |
LUNG OPACITY |
1 |
0.0004 |
| 314 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 315 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 316 |
LIP BLISTER |
1 |
0.0004 |
| 317 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 318 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
0.0004 |
| 319 |
SECOND PRIMARY MALIGNANCY |
3 |
0.0004 |
| 320 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 321 |
TRANSAMINASES INCREASED |
8 |
0.0004 |
| 322 |
SKIN FISSURES |
7 |
0.0004 |
| 323 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 324 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 325 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 326 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 327 |
SCAB |
4 |
0.0004 |
| 328 |
FIBULA FRACTURE |
1 |
0.0003 |
| 329 |
PARAPLEGIA |
1 |
0.0003 |
| 330 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 331 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 332 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 333 |
IMMUNOSUPPRESSION |
3 |
0.0003 |
| 334 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 335 |
SQUAMOUS CELL CARCINOMA OF SKIN |
2 |
0.0003 |
| 336 |
EMERGENCY CARE |
1 |
0.0003 |
| 337 |
INSURANCE ISSUE |
5 |
0.0003 |
| 338 |
SMALL INTESTINAL OBSTRUCTION |
4 |
0.0003 |
| 339 |
ERYTHEMA MULTIFORME |
3 |
0.0003 |
| 340 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 341 |
HAEMATOTOXICITY |
3 |
0.0003 |
| 342 |
ORTHOPNOEA |
1 |
0.0003 |
| 343 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 344 |
APPLICATION SITE PRURITUS |
7 |
0.0003 |
| 345 |
APPLICATION SITE VESICLES |
2 |
0.0003 |
| 346 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 347 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 348 |
INABILITY TO AFFORD MEDICATION |
3 |
0.0003 |
| 349 |
NEPHRITIS |
1 |
0.0003 |
| 350 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 351 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 352 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 353 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 354 |
PRIAPISM |
1 |
0.0003 |
| 355 |
EOSINOPHILIA |
5 |
0.0003 |
| 356 |
POOR QUALITY PRODUCT ADMINISTERED |
3 |
0.0003 |
| 357 |
RENAL FAILURE ACUTE |
12 |
0.0003 |
| 358 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 359 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 360 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 361 |
PRODUCT PRESCRIBING ISSUE |
6 |
0.0003 |
| 362 |
STAPHYLOCOCCAL INFECTION |
9 |
0.0003 |
| 363 |
THERAPY CESSATION |
14 |
0.0003 |
| 364 |
SKIN ULCER |
7 |
0.0003 |
| 365 |
HEPATIC FUNCTION ABNORMAL |
10 |
0.0003 |
| 366 |
CHEMOTHERAPY |
1 |
0.0003 |
| 367 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 368 |
ACUTE RESPIRATORY FAILURE |
5 |
0.0003 |
| 369 |
LUNG INFECTION |
4 |
0.0003 |
| 370 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 371 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 372 |
FURUNCLE |
2 |
0.0003 |
| 373 |
HYPERPHAGIA |
1 |
0.0003 |
| 374 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 375 |
BLEPHARITIS |
1 |
0.0002 |
| 376 |
SKIN EXFOLIATION |
21 |
0.0002 |
| 377 |
HOMICIDAL IDEATION |
1 |
0.0002 |
| 378 |
NO THERAPEUTIC RESPONSE |
3 |
0.0002 |
| 379 |
INTERNATIONAL NORMALISED RATIO INCREASED |
7 |
0.0002 |
| 380 |
RECURRENT CANCER |
1 |
0.0002 |
| 381 |
HYPERURICAEMIA |
1 |
0.0002 |
| 382 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 383 |
HYPERCALCAEMIA |
3 |
0.0002 |
| 384 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
2 |
0.0002 |
| 385 |
ACUTE CORONARY SYNDROME |
2 |
0.0002 |
| 386 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 387 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 388 |
COAGULOPATHY |
4 |
0.0002 |
| 389 |
CONGESTIVE CARDIOMYOPATHY |
1 |
0.0002 |
| 390 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 391 |
FACE OEDEMA |
4 |
0.0002 |
| 392 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 393 |
HEPATIC PAIN |
1 |
0.0002 |
| 394 |
LUNG NEOPLASM |
1 |
0.0002 |
| 395 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 396 |
SHOULDER OPERATION |
1 |
0.0002 |
| 397 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6 |
0.0002 |
| 398 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 399 |
CARDIAC OPERATION |
2 |
0.0002 |
| 400 |
MONOPLEGIA |
1 |
0.0002 |
| 401 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 402 |
GASTRITIS |
6 |
0.0002 |
| 403 |
LUNG INFILTRATION |
2 |
0.0002 |
| 404 |
BRAIN NEOPLASM MALIGNANT |
1 |
0.0002 |
| 405 |
IRON DEFICIENCY |
1 |
0.0002 |
| 406 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 407 |
PATHOGEN RESISTANCE |
2 |
0.0002 |
| 408 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 409 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 410 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 411 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
5 |
0.0002 |
| 412 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 413 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 414 |
FLANK PAIN |
2 |
0.0002 |
| 415 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 416 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 417 |
CARDIAC FAILURE |
17 |
0.0002 |
| 418 |
ECZEMA |
11 |
0.0002 |
| 419 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 420 |
FAECAL INCONTINENCE |
1 |
0.0002 |
| 421 |
APHAGIA |
1 |
0.0002 |
| 422 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 423 |
TREATMENT FAILURE |
17 |
0.0002 |
| 424 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 425 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 426 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 427 |
WHITE BLOOD CELL COUNT DECREASED |
22 |
0.0002 |
| 428 |
HOSPICE CARE |
2 |
0.0002 |
| 429 |
SKIN HAEMORRHAGE |
3 |
0.0002 |
| 430 |
FOOT OPERATION |
1 |
0.0002 |
| 431 |
ANEURYSM |
1 |
0.0002 |
| 432 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 433 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 434 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0002 |
| 435 |
THERAPY NON-RESPONDER |
9 |
0.0002 |
| 436 |
LEUKOPENIA |
10 |
0.0002 |
| 437 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 438 |
PRODUCT PHYSICAL ISSUE |
4 |
0.0002 |
| 439 |
HYPOTHERMIA |
2 |
0.0002 |
| 440 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 441 |
SEPSIS |
22 |
0.0002 |
| 442 |
OEDEMA PERIPHERAL |
24 |
0.0002 |
| 443 |
THERAPY INTERRUPTED |
14 |
0.0002 |
| 444 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 445 |
ENDOCARDITIS |
1 |
0.0002 |
| 446 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 447 |
CACHEXIA |
1 |
0.0002 |
| 448 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 449 |
MALABSORPTION |
1 |
0.0002 |
| 450 |
NEUTROPENIA |
26 |
0.0002 |
| 451 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 452 |
PRODUCT USE COMPLAINT |
3 |
0.0002 |
| 453 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
3 |
0.0002 |
| 454 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 455 |
SUDDEN DEATH |
2 |
0.0002 |
| 456 |
ULCER |
3 |
0.0002 |
| 457 |
CATARACT |
11 |
0.0002 |
| 458 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 459 |
DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0002 |
| 460 |
PLEURAL EFFUSION |
11 |
0.0002 |
| 461 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 462 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 463 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 464 |
NECROSIS |
1 |
0.0002 |
| 465 |
HAEMOPTYSIS |
5 |
0.0002 |
| 466 |
CELLULITIS |
9 |
0.0002 |
| 467 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 468 |
SKIN TOXICITY |
1 |
0.0002 |
| 469 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 470 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 471 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 472 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 473 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 474 |
SKIN ATROPHY |
1 |
0.0002 |
| 475 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 476 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 477 |
ENTEROCOLITIS |
1 |
0.0002 |
| 478 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 479 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 480 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 481 |
SKIN WARM |
1 |
0.0002 |
| 482 |
AMENORRHOEA |
3 |
0.0002 |
| 483 |
BACTERAEMIA |
2 |
0.0002 |
| 484 |
CATARACT OPERATION |
1 |
0.0002 |
| 485 |
HEARING IMPAIRED |
1 |
0.0002 |
| 486 |
RASH PRURITIC |
9 |
0.0002 |
| 487 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 488 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 489 |
OLIGURIA |
1 |
0.0002 |
| 490 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 491 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 492 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 493 |
GASTRIC ULCER |
3 |
0.0002 |
| 494 |
HAEMATEMESIS |
4 |
0.0002 |
| 495 |
CHOLESTASIS |
3 |
0.0002 |
| 496 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 497 |
PROCTALGIA |
1 |
0.0002 |
| 498 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 499 |
ANOREXIA |
2 |
0.0002 |
| 500 |
HERNIA |
3 |
0.0002 |
| 501 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 502 |
INCOHERENT |
1 |
0.0002 |
| 503 |
HERPES SIMPLEX |
1 |
0.0002 |
| 504 |
HAEMORRHOIDS |
3 |
0.0002 |
| 505 |
NODULE |
2 |
0.0002 |
| 506 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 507 |
BRADYPHRENIA |
1 |
0.0002 |
| 508 |
SKIN IRRITATION |
7 |
0.0002 |
| 509 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 510 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 511 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 512 |
FEBRILE NEUTROPENIA |
10 |
0.0002 |
| 513 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 514 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 515 |
PAIN OF SKIN |
4 |
0.0001 |
| 516 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 517 |
TASTE DISORDER |
3 |
0.0001 |
| 518 |
PRODUCT TASTE ABNORMAL |
2 |
0.0001 |
| 519 |
NEUTROPHIL COUNT DECREASED |
6 |
0.0001 |
| 520 |
TREATMENT NONCOMPLIANCE |
8 |
0.0001 |
| 521 |
INFARCTION |
1 |
0.0001 |
| 522 |
ECCHYMOSIS |
1 |
0.0001 |
| 523 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 524 |
INTERSTITIAL LUNG DISEASE |
7 |
0.0001 |
| 525 |
ENCEPHALITIS |
1 |
0.0001 |
| 526 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 527 |
PULMONARY HYPERTENSION |
3 |
0.0001 |
| 528 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 529 |
DERMATITIS |
3 |
0.0001 |
| 530 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 531 |
MOUTH ULCERATION |
3 |
0.0001 |
| 532 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 533 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 534 |
DUODENAL ULCER |
1 |
0.0001 |
| 535 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 536 |
DIALYSIS |
2 |
0.0001 |
| 537 |
METASTASIS |
1 |
0.0001 |
| 538 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 539 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 540 |
SKIN CANCER |
3 |
0.0001 |
| 541 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 542 |
ORAL DISORDER |
1 |
0.0001 |
| 543 |
ANAEMIA |
26 |
0.0001 |
| 544 |
SENSITIVE SKIN |
1 |
0.0001 |
| 545 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 546 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 547 |
DEHYDRATION |
18 |
0.0001 |
| 548 |
ARTHROPOD BITE |
1 |
0.0001 |
| 549 |
NEOPLASM MALIGNANT |
9 |
0.0001 |
| 550 |
PULMONARY MASS |
2 |
0.0001 |
| 551 |
COLON CANCER |
2 |
0.0001 |
| 552 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 553 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 554 |
PAROSMIA |
1 |
0.0001 |
| 555 |
PEMPHIGOID |
1 |
0.0001 |
| 556 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 557 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 558 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 559 |
ACIDOSIS |
1 |
0.0001 |
| 560 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 561 |
SHOCK |
3 |
0.0001 |
| 562 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 563 |
DELUSION |
2 |
0.0001 |
| 564 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 565 |
CONDITION AGGRAVATED |
39 |
0.0001 |
| 566 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 567 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 568 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 569 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 570 |
RENAL CYST |
1 |
0.0001 |
| 571 |
GINGIVAL PAIN |
1 |
0.0001 |
| 572 |
ABSCESS |
2 |
0.0001 |
| 573 |
PANCYTOPENIA |
7 |
0.0001 |
| 574 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 575 |
DECUBITUS ULCER |
1 |
0.0001 |
| 576 |
PRURITUS |
47 |
0.0001 |
| 577 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 578 |
OSTEONECROSIS |
4 |
0.0001 |
| 579 |
ERYTHEMA |
25 |
0.0001 |
| 580 |
ABASIA |
3 |
0.0001 |
| 581 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 582 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 583 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 584 |
EMBOLISM |
1 |
0.0001 |
| 585 |
SKIN DISORDER |
4 |
0.0001 |
| 586 |
HAEMODIALYSIS |
1 |
0.0001 |
| 587 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 588 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 589 |
HAEMATURIA |
4 |
0.0001 |
| 590 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 591 |
THROMBOCYTOPENIA |
13 |
0.0001 |
| 592 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 593 |
CARDIAC MURMUR |
1 |
0.0001 |
| 594 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 595 |
DEAFNESS |
3 |
0.0001 |
| 596 |
MUCOSAL INFLAMMATION |
3 |
0.0001 |
| 597 |
NAIL DISORDER |
1 |
0.0001 |
| 598 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 599 |
METASTASES TO LIVER |
2 |
0.0001 |
| 600 |
HYPOXIA |
4 |
0.0001 |
| 601 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 602 |
PRODUCT USE IN UNAPPROVED INDICATION |
28 |
0.0001 |
| 603 |
ATRIAL FIBRILLATION |
11 |
0.0001 |
| 604 |
LIVER DISORDER |
5 |
0.0001 |
| 605 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 606 |
FACIAL PAIN |
1 |
0.0001 |
| 607 |
MYALGIA |
19 |
0.0001 |
| 608 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 609 |
JAUNDICE |
3 |
0.0001 |
| 610 |
INFECTION |
16 |
0.0001 |
| 611 |
PNEUMONITIS |
3 |
0.0001 |
| 612 |
EXOSTOSIS |
1 |
0.0001 |
| 613 |
NEPHROLITHIASIS |
5 |
0.0001 |
| 614 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 615 |
DYSURIA |
4 |
0.0001 |
| 616 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 617 |
DIVERTICULITIS |
3 |
0.0001 |
| 618 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 619 |
WOUND |
3 |
0.0001 |
| 620 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 621 |
DRUG INTERACTION |
17 |
0.0001 |
| 622 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 623 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 624 |
BLISTER |
6 |
0.0001 |
| 625 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 626 |
ABORTION INDUCED |
1 |
0.0001 |
| 627 |
LEUKAEMIA |
1 |
0.0001 |
| 628 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 629 |
PNEUMONIA |
34 |
0.0001 |
| 630 |
DRY SKIN |
14 |
0.0001 |
| 631 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 632 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 633 |
ATELECTASIS |
1 |
0.0001 |
| 634 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 635 |
EAR PAIN |
2 |
0.0001 |
| 636 |
HEPATIC ENZYME INCREASED |
7 |
0.0001 |
| 637 |
LUNG DISORDER |
5 |
0.0001 |
| 638 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 639 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 640 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 641 |
PREGNANCY |
2 |
0.0001 |
| 642 |
BRAIN INJURY |
1 |
0.0001 |
| 643 |
HEPATIC FAILURE |
3 |
0.0001 |
| 644 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 645 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 646 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 647 |
SLUGGISHNESS |
1 |
0.0001 |
| 648 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 649 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 650 |
PETECHIAE |
1 |
0.0001 |
| 651 |
RENAL PAIN |
1 |
0.0001 |
| 652 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 653 |
CHILLS |
11 |
0.0001 |
| 654 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 655 |
NIGHT SWEATS |
3 |
0.0001 |
| 656 |
CONFUSIONAL STATE |
15 |
0.0001 |
| 657 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 658 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 659 |
OEDEMA |
5 |
0.0001 |
| 660 |
CHRONIC KIDNEY DISEASE |
7 |
0.0001 |
| 661 |
SKIN LACERATION |
1 |
0.0001 |
| 662 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 663 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 664 |
ASPIRATION |
1 |
0.0001 |
| 665 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 666 |
FOOT DEFORMITY |
1 |
0.0001 |
| 667 |
FUNGAL INFECTION |
3 |
0.0001 |
| 668 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 669 |
RASH PAPULAR |
2 |
0.0001 |
| 670 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 671 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 672 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 673 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 674 |
REBOUND EFFECT |
1 |
0.0001 |
| 675 |
DEATH |
76 |
0.0001 |
| 676 |
FLATULENCE |
5 |
0.0001 |
| 677 |
OFF LABEL USE |
77 |
0.0001 |
| 678 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 679 |
HAEMOGLOBIN DECREASED |
9 |
0.0001 |
| 680 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 681 |
TINNITUS |
4 |
0.0001 |
| 682 |
SKIN DISCOLOURATION |
4 |
0.0001 |
| 683 |
NEOPLASM |
1 |
0.0001 |
| 684 |
LETHARGY |
5 |
0.0001 |
| 685 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 686 |
METASTASES TO LUNG |
1 |
0.0001 |
| 687 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 688 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 689 |
DRUG INEFFECTIVE |
113 |
0.0001 |
| 690 |
SPLENOMEGALY |
1 |
0.0001 |
| 691 |
SPINAL PAIN |
1 |
0.0001 |
| 692 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 693 |
DYSPHAGIA |
8 |
0.0001 |
| 694 |
ATAXIA |
1 |
0.0001 |
| 695 |
CHOLECYSTITIS |
1 |
0.0001 |
| 696 |
MYOCLONUS |
1 |
0.0001 |
| 697 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 698 |
POLYNEUROPATHY |
1 |
0.0001 |
| 699 |
LOCALISED INFECTION |
2 |
0.0001 |
| 700 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 701 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 702 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 703 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 704 |
CYST |
1 |
0.0001 |
| 705 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 706 |
BRAIN OEDEMA |
1 |
0.0001 |
| 707 |
WEIGHT DECREASED |
22 |
0.0001 |
| 708 |
HEPATITIS |
2 |
0.0001 |
| 709 |
PYREXIA |
27 |
0.0001 |
| 710 |
DRUG RESISTANCE |
2 |
0.0001 |
| 711 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 712 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 713 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 714 |
URINARY TRACT INFECTION |
13 |
0.0001 |
| 715 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 716 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 717 |
SOPOR |
1 |
0.0001 |
| 718 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 719 |
SWELLING |
7 |
0.0001 |
| 720 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 721 |
DRUG TOXICITY |
1 |
0.0001 |
| 722 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 723 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 724 |
CARDIAC ARREST |
6 |
0.0001 |
| 725 |
POLLAKIURIA |
3 |
0.0001 |
| 726 |
DEMENTIA |
2 |
0.0001 |
| 727 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 728 |
HYPONATRAEMIA |
4 |
0.0001 |
| 729 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 730 |
HYPOACUSIS |
3 |
0.0001 |
| 731 |
HERPES ZOSTER |
4 |
0.0001 |
| 732 |
PRODUCT SUBSTITUTION ISSUE |
4 |
0.0001 |
| 733 |
PANCREATIC CARCINOMA |
2 |
0.0001 |
| 734 |
GENERAL PHYSICAL HEALTH DETERIORATION |
8 |
0.0001 |
| 735 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 736 |
DECREASED APPETITE |
16 |
0.0001 |
| 737 |
CONSTIPATION |
15 |
0.0001 |
| 738 |
RESPIRATORY FAILURE |
5 |
0.0001 |
| 739 |
DYSSTASIA |
2 |
0.0001 |
| 740 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 741 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 742 |
ABDOMINAL DISTENSION |
7 |
0.0001 |
| 743 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 744 |
PRODUCT QUALITY ISSUE |
9 |
0.0001 |
| 745 |
APHASIA |
2 |
0.0001 |
| 746 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 747 |
OSTEOPENIA |
1 |
0.0001 |
| 748 |
PLATELET COUNT DECREASED |
7 |
0.0001 |
| 749 |
VERTIGO |
4 |
0.0001 |
| 750 |
MUSCLE SPASMS |
12 |
0.0001 |
| 751 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 752 |
ADVERSE EVENT |
6 |
0.0001 |
| 753 |
HOSPITALISATION |
10 |
0.0001 |
| 754 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 755 |
FATIGUE |
50 |
0.0001 |
| 756 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 757 |
ASTHENIA |
24 |
0.0001 |
| 758 |
PNEUMOTHORAX |
1 |
0.0001 |
| 759 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 760 |
OBESITY |
1 |
0.0001 |
| 761 |
HIP FRACTURE |
2 |
0.0001 |
| 762 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 763 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 764 |
METASTASES TO BONE |
1 |
0.0001 |
| 765 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 766 |
RENAL FAILURE |
8 |
0.0001 |
| 767 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 768 |
VIRAL INFECTION |
2 |
0.0001 |
| 769 |
URINARY RETENTION |
2 |
0.0001 |
| 770 |
RASH |
26 |
0.0001 |
| 771 |
PERICARDITIS |
1 |
0.0001 |
| 772 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 773 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 774 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 775 |
SCAR |
1 |
0.0001 |
| 776 |
GASTRIC DISORDER |
2 |
0.0001 |
| 777 |
INFLAMMATION |
3 |
0.0001 |
| 778 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 779 |
PARANOIA |
1 |
0.0001 |
| 780 |
BALANCE DISORDER |
5 |
0.0001 |
| 781 |
RASH MACULAR |
2 |
0.0001 |
| 782 |
HEART RATE DECREASED |
2 |
0.0001 |
| 783 |
COLD SWEAT |
1 |
0.0001 |
| 784 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 785 |
TACHYCARDIA |
5 |
0.0001 |
| 786 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 787 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 788 |
PELVIC PAIN |
1 |
0.0001 |
| 789 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 790 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 791 |
BONE DISORDER |
1 |
0.0001 |
| 792 |
PANIC ATTACK |
2 |
0.0001 |
| 793 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 794 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 795 |
EYE SWELLING |
2 |
0.0001 |
| 796 |
NECK PAIN |
3 |
0.0001 |
| 797 |
EPISTAXIS |
4 |
0.0001 |
| 798 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 799 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 800 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 801 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 802 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 803 |
ABDOMINAL PAIN |
12 |
0.0001 |
| 804 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 805 |
CHOKING |
1 |
0.0001 |
| 806 |
ORAL HERPES |
1 |
0.0001 |
| 807 |
SURGERY |
3 |
0.0001 |
| 808 |
KIDNEY INFECTION |
1 |
0.0001 |
| 809 |
DISORIENTATION |
2 |
0.0001 |
| 810 |
CARDIAC FAILURE CONGESTIVE |
4 |
0.0000 |
| 811 |
DISCOMFORT |
3 |
0.0000 |
| 812 |
FEELING HOT |
3 |
0.0000 |
| 813 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 814 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 815 |
PERITONITIS |
1 |
0.0000 |
| 816 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 817 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 818 |
EATING DISORDER |
1 |
0.0000 |
| 819 |
RETCHING |
1 |
0.0000 |
| 820 |
NAUSEA |
37 |
0.0000 |
| 821 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 822 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 823 |
DYSPNOEA |
26 |
0.0000 |
| 824 |
ALOPECIA |
9 |
0.0000 |
| 825 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 826 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 827 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 828 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 829 |
MELAENA |
1 |
0.0000 |
| 830 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 831 |
HYPOTENSION |
9 |
0.0000 |
| 832 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 833 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 834 |
MEMORY IMPAIRMENT |
6 |
0.0000 |
| 835 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 836 |
CHEST PAIN |
8 |
0.0000 |
| 837 |
INJURY |
3 |
0.0000 |
| 838 |
PAIN |
26 |
0.0000 |
| 839 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 840 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 841 |
ABDOMINAL DISCOMFORT |
7 |
0.0000 |
| 842 |
HEADACHE |
26 |
0.0000 |
| 843 |
PRESYNCOPE |
1 |
0.0000 |
| 844 |
NEURALGIA |
1 |
0.0000 |
| 845 |
HEART RATE INCREASED |
4 |
0.0000 |
| 846 |
WEIGHT INCREASED |
9 |
0.0000 |
| 847 |
AGEUSIA |
1 |
0.0000 |
| 848 |
HALLUCINATION |
3 |
0.0000 |
| 849 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 850 |
FLUSHING |
4 |
0.0000 |
| 851 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 852 |
HYPOPHAGIA |
1 |
0.0000 |
| 853 |
FALL |
13 |
0.0000 |
| 854 |
ABDOMINAL PAIN UPPER |
8 |
0.0000 |
| 855 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 856 |
HAEMATOMA |
1 |
0.0000 |
| 857 |
DIPLOPIA |
1 |
0.0000 |
| 858 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 859 |
SPEECH DISORDER |
2 |
0.0000 |
| 860 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 861 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 862 |
PANCREATITIS |
2 |
0.0000 |
| 863 |
DEPRESSED MOOD |
2 |
0.0000 |
| 864 |
BLOOD GLUCOSE INCREASED |
7 |
0.0000 |
| 865 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 866 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 867 |
DRY MOUTH |
3 |
0.0000 |
| 868 |
LIMB INJURY |
1 |
0.0000 |
| 869 |
DRUG DOSE OMISSION |
6 |
0.0000 |
| 870 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 871 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 872 |
VOMITING |
17 |
0.0000 |
| 873 |
DIZZINESS |
18 |
0.0000 |
| 874 |
FEELING COLD |
1 |
0.0000 |
| 875 |
TOXICITY TO VARIOUS AGENTS |
6 |
0.0000 |
| 876 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 877 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 878 |
HYPERSOMNIA |
1 |
0.0000 |
| 879 |
BACK PAIN |
8 |
0.0000 |
| 880 |
MYOCARDIAL INFARCTION |
6 |
0.0000 |
| 881 |
DYSPHONIA |
2 |
0.0000 |
| 882 |
ASCITES |
1 |
0.0000 |
| 883 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 884 |
FEELING ABNORMAL |
8 |
0.0000 |
| 885 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 886 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 887 |
EPILEPSY |
1 |
0.0000 |
| 888 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 889 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 890 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 891 |
FEMUR FRACTURE |
1 |
0.0000 |
| 892 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 893 |
COUGH |
9 |
0.0000 |
| 894 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 895 |
HEAD INJURY |
1 |
0.0000 |
| 896 |
CYSTITIS |
1 |
0.0000 |
| 897 |
ARTHRALGIA |
13 |
0.0000 |
| 898 |
DIARRHOEA |
20 |
0.0000 |
| 899 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 900 |
DEPRESSION |
7 |
0.0000 |
| 901 |
SWELLING FACE |
2 |
0.0000 |
| 902 |
DYSPEPSIA |
3 |
0.0000 |
| 903 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 904 |
LIP SWELLING |
1 |
0.0000 |
| 905 |
SYNCOPE |
3 |
0.0000 |
| 906 |
EYE PRURITUS |
1 |
0.0000 |
| 907 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 908 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 909 |
VISION BLURRED |
4 |
0.0000 |
| 910 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 911 |
DELIRIUM |
1 |
0.0000 |
| 912 |
HYPERKALAEMIA |
1 |
0.0000 |
| 913 |
COVID-19 |
5 |
0.0000 |
| 914 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 915 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 916 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 917 |
AGITATION |
2 |
0.0000 |
| 918 |
BRONCHITIS |
2 |
0.0000 |
| 919 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 920 |
DYSGEUSIA |
2 |
0.0000 |
| 921 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 922 |
COLITIS |
1 |
0.0000 |
| 923 |
ACNE |
2 |
0.0000 |
| 924 |
DIABETES MELLITUS |
2 |
0.0000 |
| 925 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 926 |
ANXIETY |
7 |
0.0000 |
| 927 |
TREMOR |
4 |
0.0000 |
| 928 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 929 |
URTICARIA |
4 |
0.0000 |
| 930 |
HYPERHIDROSIS |
3 |
0.0000 |
| 931 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 932 |
MALAISE |
10 |
0.0000 |
| 933 |
INSOMNIA |
6 |
0.0000 |
| 934 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 935 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 936 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 937 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 938 |
HYPOKALAEMIA |
1 |
0.0000 |
| 939 |
RENAL DISORDER |
1 |
0.0000 |
| 940 |
ARRHYTHMIA |
1 |
0.0000 |
| 941 |
COMA |
1 |
0.0000 |
| 942 |
RENAL CANCER |
1 |
0.0000 |
| 943 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 944 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 945 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 946 |
CONTUSION |
2 |
0.0000 |
| 947 |
DRY EYE |
1 |
0.0000 |
| 948 |
AGGRESSION |
1 |
0.0000 |
| 949 |
FLUID RETENTION |
1 |
0.0000 |
| 950 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 951 |
SINUSITIS |
2 |
0.0000 |
| 952 |
ILLNESS |
2 |
0.0000 |
| 953 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 954 |
HAEMORRHAGE |
2 |
0.0000 |
| 955 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 956 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 957 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 958 |
MEDICATION ERROR |
1 |
0.0000 |
| 959 |
INFLUENZA |
2 |
0.0000 |
| 960 |
CONVULSION |
1 |
0.0000 |
| 961 |
SEIZURE |
2 |
0.0000 |
| 962 |
NASAL CONGESTION |
1 |
0.0000 |
| 963 |
IRRITABILITY |
1 |
0.0000 |
| 964 |
JOINT SWELLING |
2 |
0.0000 |
| 965 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 966 |
STOMATITIS |
1 |
0.0000 |
| 967 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 968 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 969 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 970 |
RHINORRHOEA |
1 |
0.0000 |
| 971 |
AMNESIA |
1 |
0.0000 |
| 972 |
SOMNOLENCE |
3 |
0.0000 |
| 973 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 974 |
BURNING SENSATION |
1 |
0.0000 |
| 975 |
HYPERTENSION |
3 |
0.0000 |
| 976 |
MOBILITY DECREASED |
1 |
0.0000 |
| 977 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 978 |
HYPOAESTHESIA |
2 |
0.0000 |
| 979 |
HOT FLUSH |
1 |
0.0000 |
| 980 |
ARTHRITIS |
1 |
0.0000 |
| 981 |
PROSTATE CANCER |
1 |
0.0000 |
| 982 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 983 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 984 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 985 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 986 |
BREAST CANCER |
1 |
0.0000 |
| 987 |
CARDIAC DISORDER |
1 |
0.0000 |
| 988 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 989 |
PALPITATIONS |
1 |
0.0000 |
| 990 |
PSORIASIS |
1 |
0.0000 |
| 991 |
OVERDOSE |
1 |
0.0000 |
| 992 |
INJECTION SITE PAIN |
1 |
0.0000 |